ORBIMED ADVISORS LLC Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$7.9B
Holdings
130
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (130 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BIIBBIOGEN INC | 1,230,700 | $392.1B | 4959.24% | |
| 2 | ALXNALEXION PHARMACEUTICALS INC | 2,879,575 | $344.4B | 4355.93% | |
| 3 | CELGCELGENE CORP | 3,212,850 | $335.3B | 4241.14% | Call |
| 4 | REGNREGENERON PHARMACEUTICALS | 854,600 | $321.3B | 4064.08% | |
| 5 | VRTXVERTEX PHARMACEUTICALS INC | 1,741,300 | $261.0B | 3300.79% | |
| 6 | BSXBOSTON SCIENTIFIC CORP | 10,386,600 | $257.5B | 3256.93% | |
| 7 | AMGNAMGEN INC | 1,297,100 | $225.6B | 2853.20% | |
| 8 | PBYIPUMA BIOTECHNOLOGY INC | 2,184,535 | $215.9B | 2731.45% | |
| 9 | MRKMERCK & CO INC | 3,625,400 | $204.0B | 2580.42% | |
| 10 | —CLEMENTIA PHARMACEUTICALS IN | 10,425,225 | $197.9B | 2502.88% | |
| 11 | CICIGNA CORPORATION | 969,300 | $196.9B | 2490.03% | |
| 12 | LLYLILLY ELI & CO | 2,288,000 | $193.2B | 2444.36% | |
| 13 | AG8AGILENT TECHNOLOGIES INC | 2,590,700 | $173.5B | 2194.60% | |
| 14 | —WRIGHT MED GROUP N V | 6,852,068 | $152.1B | 1924.13% | |
| 15 | ELVANTHEM INC | 658,718 | $148.2B | 1874.82% | |
| 16 | —IMMUNOMEDICS INC | 8,461,727 | $136.7B | 1729.66% | |
| 17 | ASNDASCENDIS PHARMA A S | 3,367,315 | $134.9B | 1706.30% | |
| 18 | CLVSEURCLOVIS ONCOLOGY INC | 1,971,670 | $134.1B | 1695.91% | |
| 19 | —AUDENTES THERAPEUTICS INC | 4,129,638 | $129.1B | 1632.37% | |
| 20 | EWEDWARDS LIFESCIENCES CORP | 1,124,100 | $126.7B | 1602.60% | |
| 21 | ALNYALNYLAM PHARMACEUTICALS INC | 941,600 | $119.6B | 1513.21% | |
| 22 | ONCBEIGENE LTD | 1,041,488 | $101.8B | 1287.35% | |
| 23 | ABBVABBVIE INC | 1,050,600 | $101.6B | 1285.20% | |
| 24 | ARRYEURARRAY BIOPHARMA INC | 7,621,400 | $97.6B | 1233.97% | |
| 25 | SEMSELECT MED HLDGS CORP | 5,074,200 | $89.6B | 1132.85% | |
| 26 | VRAYQVIEWRAY INC | 9,458,567 | $87.6B | 1107.88% | |
| 27 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 2,157,730 | $84.9B | 1073.99% | |
| 28 | —JUNO THERAPEUTICS INC | 1,835,188 | $83.9B | 1061.08% | |
| 29 | —MAGELLAN HEALTH INC | 855,843 | $82.6B | 1045.22% | |
| 30 | JAZZJAZZ PHARMACEUTICALS PLC | 607,900 | $81.9B | 1035.38% | |
| 31 | —AETNA INC NEW | 447,552 | $80.7B | 1021.21% | |
| 32 | AM6AMICUS THERAPEUTICS INC | 5,572,500 | $80.2B | 1014.30% | |
| 33 | AERIEURAERIE PHARMACEUTICALS INC | 1,329,600 | $79.4B | 1004.89% | |
| 34 | —LOXO ONCOLOGY INC | 94,100,036 | $79.2B | 1001.97% | |
| 35 | —MYLAN N V | 1,834,300 | $77.6B | 981.68% | |
| 36 | TMOTHERMO FISHER SCIENTIFIC INC | 389,400 | $73.9B | 935.26% | |
| 37 | IRWDIRONWOOD PHARMACEUTICALS INC | 4,925,200 | $73.8B | 933.87% | Call |
| 38 | ILMNILLUMINA INC | 328,500 | $71.8B | 907.87% | |
| 39 | —BLUEBIRD BIO INC | 384,046 | $68.4B | 865.18% | |
| 40 | JNJJOHNSON & JOHNSON | 465,300 | $65.0B | 822.34% | |
| 41 | NVROEURNEVRO CORP | 897,791 | $62.0B | 784.03% | |
| 42 | ISRGINTUITIVE SURGICAL INC | 153,600 | $56.1B | 709.04% | |
| 43 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $55.7B | 704.93% | |
| 44 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $54.8B | 693.30% | |
| 45 | ASMBASSEMBLY BIOSCIENCES INC | 1,198,026 | $54.2B | 685.72% | |
| 46 | UNHUNITEDHEALTH GROUP INC | 239,500 | $52.8B | 667.87% | |
| 47 | INSYEURINSYS THERAPEUTICS INC NEW | 5,406,844 | $52.0B | 657.93% | |
| 48 | —ALLERGAN PLC | 287,290 | $47.0B | 594.44% | |
| 49 | IM8NINSMED INC | 1,496,791 | $46.7B | 590.33% | |
| 50 | GLPGGALAPAGOS NV | 486,990 | $45.7B | 577.56% | |
| 51 | NTLAINTELLIA THERAPEUTICS INC | 2,337,684 | $44.9B | 568.32% | |
| 52 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,548,326 | $44.4B | 561.45% | |
| 53 | SYKSTRYKER CORP | 286,000 | $44.3B | 560.15% | |
| 54 | KALAKALA PHARMACEUTICALS INC | 2,375,279 | $43.9B | 555.53% | |
| 55 | —RADIUS HEALTH INC | 1,371,700 | $43.6B | 551.23% | |
| 56 | RYTMRHYTHM PHARMACEUTICALS INC | 2,901,295 | $43.5B | 550.47% | |
| 57 | —SHIRE PLC | 272,508 | $42.3B | 534.69% | |
| 58 | BMYBRISTOL MYERS SQUIBB CO | 688,000 | $42.2B | 533.30% | |
| 59 | —ALLERGAN PLC | 71,700 | $42.0B | 531.69% | |
| 60 | SCPHSCPHARMACEUTICALS INC | 3,409,865 | $41.2B | 521.46% | |
| 61 | GILDGILEAD SCIENCES INC | 521,600 | $37.4B | 472.66% | |
| 62 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,298,516 | $36.9B | 467.29% | |
| 63 | PFEPFIZER INC | 982,000 | $35.6B | 449.90% | |
| 64 | DVADAVITA INC | 477,400 | $34.5B | 436.29% | |
| 65 | IARTINTEGRA LIFESCIENCES HLDGS C | 711,710 | $34.1B | 430.85% | |
| 66 | —DERMIRA INC | 1,181,168 | $32.8B | 415.50% | |
| 67 | EHTHEHEALTH INC | 1,834,700 | $31.9B | 403.11% | |
| 68 | ARGXARGENX SE | 500,000 | $31.6B | 399.33% | |
| 69 | —ENVISION HEALTHCARE CORP | 875,400 | $30.3B | 382.68% | |
| 70 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,176,070 | $26.7B | 337.25% | |
| 71 | ACADACADIA PHARMACEUTICALS INC | 849,100 | $25.6B | 323.39% | |
| 72 | —OBSEVA SA | 2,605,531 | $25.4B | 321.67% | |
| 73 | —ARSANIS INC | 1,868,966 | $23.8B | 301.65% | |
| 74 | —ACHILLION PHARMACEUTICALS IN | 8,170,973 | $23.5B | 297.66% | |
| 75 | —NABRIVA THERAPEUTICS PLC | 3,919,600 | $23.4B | 296.48% | |
| 76 | XNCRXENCOR INC | 1,022,100 | $22.4B | 283.39% | |
| 77 | SVASINOVAC BIOTECH LTD | 2,839,500 | $22.4B | 283.02% | |
| 78 | GKOSGLAUKOS CORP | 836,500 | $21.5B | 271.40% | |
| 79 | MDTMEDTRONIC PLC | 254,200 | $20.5B | 259.65% | |
| 80 | UHSUNIVERSAL HLTH SVCS INC | 174,800 | $19.8B | 250.63% | |
| 81 | IMGNEURIMMUNOGEN INC | 2,834,126 | $18.2B | 229.80% | |
| 82 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $18.1B | 228.67% | |
| 83 | NVONOVO-NORDISK A S | 330,000 | $17.7B | 224.03% | |
| 84 | —STEADYMED LTD | 4,246,196 | $15.7B | 198.73% | |
| 85 | —MOMENTA PHARMACEUTICALS INC | 1,125,900 | $15.7B | 198.67% | |
| 86 | VRNAVERONA PHARMA PLC | 1,250,396 | $14.8B | 187.75% | |
| 87 | VNDAVANDA PHARMACEUTICALS INC | 967,859 | $14.7B | 186.08% | |
| 88 | —DBV TECHNOLOGIES S A | 578,500 | $14.2B | 180.01% | |
| 89 | NTRANATERA INC | 1,576,190 | $14.2B | 179.24% | |
| 90 | ZLABZAI LAB LTD | 658,160 | $14.0B | 176.75% | |
| 91 | NVTA1EURINVITAE CORP | 1,518,197 | $13.8B | 174.37% | |
| 92 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $13.4B | 169.50% | |
| 93 | —WRIGHT MED GROUP N V | 8,746,583 | $13.2B | 167.06% | |
| 94 | CHRSCOHERUS BIOSCIENCES INC | 1,471,500 | $12.9B | 163.79% | |
| 95 | NUVAGBPNUVASIVE INC | 220,700 | $12.9B | 163.29% | |
| 96 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,914,660 | $12.8B | 161.78% | |
| 97 | —SYNLOGIC INC | 1,314,996 | $12.8B | 161.34% | |
| 98 | —AEGERION PHARMACEUTICALS INC | 15,000,000 | $12.0B | 151.86% | |
| 99 | —SIERRA ONCOLOGY INC | 3,203,704 | $11.9B | 151.16% | |
| 100 | HRTXHERON THERAPEUTICS INC | 650,000 | $11.8B | 148.82% |
Page 1 of 2Next